Back to trial details

Intake questionnaire

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Applying to University Gastroenterology Providence · Providence, Rhode Island

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 18 and 75 years old?
2. Have you been diagnosed with Crohn's Disease?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Providence for study visits?